NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has acquired Israeli synthetic biology software company Genome Compiler.

Under the terms of the agreement, the Genome Compiler research and development center in Israel will remain open as Twist's first international site. Financial terms of the deal were not disclosed.

Twist said it plans to use Genome Compiler's technology and expertise to develop a digital products portfolio, including an e-commerce solution with gene design capabilities, which is expected to be available in the second half of 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.